Citation Impact
Citing Papers
Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells.
1999
EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines
2002
Hallmarks of Cancer: The Next Generation
2011 Standout
Immunotherapy of cancer in 2012
2012
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses
2016
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
mRNA-based dendritic cell vaccines
2014
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
2015
A view on drug resistance in cancer
2019 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments
2011
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis
2018
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
2006
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
2016
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis
2019
Telomere states and cell fates
2000 StandoutNatureNobel
PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients
2013
Cancer immunotherapy via dendritic cells
2012 Standout
A listing of human tumor antigens recognized by T cells
2001
New horizons in adjuvants for vaccine development
2020
TGFβ: the molecular Jekyll and Hyde of cancer
2006
Mechanisms of disseminated cancer cell dormancy: an awakening field
2014
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Metazoan MicroRNAs
2018 Standout
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
2023
Gliomagenesis: genetic alterations and mouse models
2001
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
2015
Dendritic cells in cancer immunotherapy
2010
Immunity, Inflammation, and Cancer
2010 Standout
Malignant Gliomas in Adults
2008 Standout
Atopy and Risk of Brain Tumors: A Meta-analysis
2007
Emerging Biological Principles of Metastasis
2017 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Targeting metastasis
2016
TGFβ in Cancer
2008 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
2010
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
2017
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
2010
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
2017
Clonal evolution in cancer
2012 StandoutNature
The PI3K Pathway in Human Disease
2017 Standout
Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
2012
Identification of human brain tumour initiating cells
2004 StandoutNature
CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration
1999
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Perturbation of Hyaluronan Interactions Inhibits Malignant Properties of Glioma Cells
2003
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Clinical relevance of tumour-associated macrophages
2022
Innate immune signaling and regulation in cancer immunotherapy
2016
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
Hyaluronate Receptors Mediating Glioma Cell Migration and Proliferation
2001
Homing Phenotypes of Tumor-Specific CD8 T Cells Are Predetermined at the Tumor Site by Crosspresenting APCs
2005
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Alerting the immune system via stromal cells is central to the prevention of tumor growth
2013
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
IL-10–Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function
2016
<p>LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression</p>
2019
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation
1998
Therapeutic Targeting of the Tumor Microenvironment
2021
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Transcriptional regulation of myeloid-derived suppressor cells
2015
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Metabolic reprogramming and cancer progression
2020 StandoutScience
Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
2018
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
2001
Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells
2007
CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
1999
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
2006
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
CAR T cell immunotherapy for human cancer
2018 StandoutScience
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Polyunsaturated fatty acids promote the expansion of myeloid‐derived suppressor cells by activating the JAK /STAT 3 pathway
2013
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
2017
Works of Hideho Okada being referenced
Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
2014
Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
2010
STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
2014
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
2011
Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10
2009
GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α
2013
Stat6 Signaling Suppresses VLA-4 Expression by CD8+ T Cells and Limits Their Ability to Infiltrate Tumor Lesions In Vivo
2008
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
2007
Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors
2005
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
2017
Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes overexpressed CD44 in glioma cells
1994
Suppression of CD44 expression decreases migration and invasion of human glioma cells
1996
Sequential delivery of interferon-α gene and DCs to intracranial gliomas promotes an effective antitumor response
2004
MicroRNAs and STAT interplay
2011
Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms
1998
Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy
2017
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
2015
EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines
2005
IL‐4 inhibits VLA‐4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit
2008
Premetastatic soil and prevention of breast cancer brain metastasis
2013
Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
2010
Expression of antigen processing and presenting molecules in brain metastasis of breast cancer
2011
Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells
2001
Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials
2015
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy
2003
Exploitation of immune mechanisms in the treatment of central nervous system cancer
2000
MicroRNAs in immune regulation—Opportunities for cancer immunotherapy
2010
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
2011
Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo
2003
Pilot study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma.
2016
IMCT-15PILOT STUDY OF T CELLS REDIRECTED TO EGFRvIII WITH A CHIMERIC ANTIGEN RECEPTOR IN PATIENTS WITH EGFRvIII+ GLIOBLASTOMA
2015
Abstract 4754: Type-1 dendritic cell vaccines in combination with poly-ICLC-association between positive tetramer response and 6-month progression-free survival in patients with recurrent malignant glioma
2010
Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma
2008
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
2017
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
2009
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain.
2002
Delivery of Interferon-α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines
2004
Induction of CD8+T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
2010
Identification of Interleukin-13 Receptor α2 Peptide Analogues Capable of Inducing Improved Antiglioma CTL Responses
2006
Vaccines Targeting Tumor Blood Vessel Antigens Promote CD8+ T Cell-Dependent Tumor Eradication or Dormancy in HLA-A2 Transgenic Mice
2012
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
2018
Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
2002
Delivery of Dendritic Cells Engineered to Secrete IFN-α into Central Nervous System Tumors Enhances the Efficacy of Peripheral Tumor Cell Vaccines: Dependence on Apoptotic Pathways
2005
Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
2000